• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.60% Nasdaq Down0.39%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    10.48 Up 0.03(0.29%) Feb 11, 4:00PM EST
    |After Hours : 10.48 0.00 (0.00%) Feb 11, 4:35PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 13,795   44,901   8,562   21,179  
    Cost of Revenue -   -   -   -  
    Gross Profit 13,795   44,901   8,562   21,179  
    Operating Expenses
    Research Development31,733  33,984  22,749  26,193  
    Selling General and Administrative12,459  13,329  7,890  11,125  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (30,397) (2,412) (22,077) (16,139)
    Income from Continuing Operations
    Total Other Income/Expenses Net347  190  200  158  
    Earnings Before Interest And Taxes(30,050)(2,222)(21,877)(15,981)
    Interest Expense -   -   -   -  
    Income Before Tax(30,050)(2,222)(21,877)(15,981)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(30,050)(2,222)(21,877)(15,981)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (30,050) (2,222) (21,877) (15,981)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (30,050) (2,222) (21,877) (15,981)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.